Complex bacterial infections pre- and posttransplant

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 2, 2010, Pages 234-242

  Lease, Erika D ^a   Zaas, David W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Burkholderia; Cystic fibrosis; Lung transplant; Mycobacteria; Pneumonia; Pseudomonas

Indexed keywords

AMINOGLYCOSIDE; ANTIMYCOBACTERIAL AGENT; CYCLOSPORIN; ISONIAZID; RAPAMYCIN; RIFAMYCIN; TACROLIMUS;

BACTERIAL INFECTION; BURKHOLDERIA; BURKHOLDERIA GLADIOLI; BURKHOLDERIA INFECTION; DRUG ANTAGONISM; GRAFT INFECTION; HUMAN; INFECTION RISK; LUNG TRANSPLANTATION; MYCOBACTERIUM TUBERCULOSIS; NEPHROTOXICITY; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STENOTROPHOMONAS MALTOPHILIA;

BACTERIAL INFECTIONS; HUMANS; LUNG TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 77950525463     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1249119     Document Type: Review

References (47)

1. Bonvillain R W., Valentine V G., Lombard G, LaPlace S, Dhillon G, Wang G. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation. J Heart Lung Transplant 2007 26 890-897
2. Aguilar-Guisado M, Givaldá J, Ussetti P et al, RESITRA cohort. Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study. Am J Transplant 2007 7 1989-1996
3. Campos S, Caramori M, Teixeira R et al. Bacterial and fungal pneumonias after lung transplantation. Transplant Proc 2008 40 822-824
4. Valentine V G., Bonvillain R W., Gupta M R. et al. Infections in lung allograft recipients: ganciclovir era. J Heart Lung Transplant 2008 27 528-535
5. Palmer S M., Alexander B D., Sanders L L. et al. Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. Transplantation 2000 69 2360-2366
6. Hadjiliadis D, Steele M P., Chaparro C et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 2007 26 834-838
7. Orens J B., Estenne M, Arcasoy S et al, Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 updatea consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006 25 745-755
8. Kumar D, Cattral M S., Robicsek A, Gaudreau C, Humar A. Outbreak of Pseudomonas aeruginosa by multiple organ transplantation from a common donor. Transplantation 2003 75 1053-1055
9. Walter S, Gudowius P, Bosshammer J et al. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax 1997 52 318-321
10. Holzmann D, Speich R, Kaufmann T et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation 2004 77 134-136
11. Botha P, Archer L, Anderson R L. et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008 85 771-774
12. Vos R, Vanaudenaerde B M., Geudens N, Dupont L J., Van Raemdonck D E., Verleden G M. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur Respir J 2008 31 1037-1045
13. Christenson J C., Welch D F., Mukwaya G, Muszynski M J., Weaver R E., Brenner D J. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol 1989 27 270-273
14. Church A C., Sivasothy P, Parmer J, Foweraker J. Mediastinal abscess after lung transplantation secondary to Burkholderia gladioli infection. J Heart Lung Transplant 2009 28 511-514
15. Jones A M., Stanbridge T N., Isalska B J., Dodd M E., Webb A K. Burkholderia gladioli: recurrent abscesses in a patient with cystic fibrosis. J Infect 2001 42 69-71
16. Kanj S S., Tapson V, Davis R D., Madden J, Browning I. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997 112 924-930
17. Khan S U., Gordon S M., Stillwell P C., Kirby T J., Arroliga A C. Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation. Pediatr Infect Dis J 1996 15 637-639
18. Bernhardt S A., Spilker T, Coffey T, LiPuma J J. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. Clin Infect Dis 2003 37 780-785
19. Murray S, Charbeneau J, Marshall B C., LiPuma J J. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008 178 363-371
20. Kennedy M P., Coakley R D., Donaldson S H. et al. Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center. J Cyst Fibros 2007 6 267-273
21. Glass S, Govan J R. Pseudomonas cepacia fatal pulmonary infection in a patient with cystic fibrosis. J Infect 1986 13 157-158
22. De Soyza A, Corris P A. Lung transplantation and the Burkholderia cepacia complex. J Heart Lung Transplant 2003 22 954-958
23. Reik R, Spilker T, Lipuma J J. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005 43 2926-2928
24. De Soyza A, McDowell A, Archer L et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001 358 1780-1781 (Pubitemid 33153006)
25. Aris R M., Routh J C., LiPuma J J., Heath D G., Gilligan P H. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type. Am J Respir Crit Care Med 2001 164 2102-2106
26. Alexander B D., Petzold E W., Reller L B. et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008 8 1025-1030
27. de Perrot M, Chaparro C, McRae K et al. Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 2004 127 1493-1501
28. Goss C H., Otto K, Aitken M L., Rubenfeld G D. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am J Respir Crit Care Med 2002 166 356-361
29. Korenromp E L., Bierrenbach A L., Williams B G., Dye C. The measurement and estimation of tuberculosis mortality. Int J Tuberc Lung Dis 2009 13 283-303
30. Morales P, Briones A, Torres J J., Solá A, Párez D, Pastor A. Pulmonary tuberculosis in lung and heart-lung transplantation: fifteen years of experience in a single center in Spain. Transplant Proc 2005 37 4050-4055
31. Muáoz P, Rodráguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005 40 581-587 (Pubitemid 40270229)
32. Schulman L L., Scully B, McGregor C C., Austin J H. Pulmonary tuberculosis after lung transplantation. Chest 1997 111 1459-1462
33. Singh N, Paterson D L. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998 27 1266-1277
34. Dromer C, Nashef S A., Velly J F., Martigne C, Couraud L. Tuberculosis in transplanted lungs. J Heart Lung Transplant 1993 12 (6 Pt 1) 924-927
35. Malouf M A., Glanville A R. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999 160 (5 Pt 1) 1611-1616
36. Aguado J M., Herrero J A., Gavaldá J et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997 63 1278-1286
37. Boedefeld R L., Eby J, Boedefeld W M. II et al. Fatal Mycobacterium tuberculosis infection in a lung transplant recipient. J Heart Lung Transplant 2008 27 1176-1178
38. Bravo C, Roldán J, Roman A et al. Tuberculosis in lung transplant recipients. Transplantation 2005 79 59-64
39. Lee J, Yew W W., Wong C F., Wong P C., Chiu C S. Multidrug-resistant tuberculosis in a lung transplant recipient. J Heart Lung Transplant 2003 22 1168-1173
40. Fowler S J., French J, Screaton N J. et al. Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J 2006 28 1204-1210
41. Olivier K N., Weber D J., Wallace R J. Jr et al, Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003 167 828-834
42. Chalermskulrat W, Sood N, Neuringer I P. et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006 61 507-513
43. Taylor J L., Palmer S M. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant 2006 25 985-988
44. Chernenko S M., Humar A, Hutcheon M et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant 2006 25 1447-1455
45. Zaidi S, Elidemir O, Heinle J S. et al. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Transpl Infect Dis 2009 11 243-248
46. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997 156 (2 Pt 2) S1-S25
47. Doucette K, Fishman J A. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004 38 1428-1439